Different concomitant approaches were tested in association with WBRT (cytotoxics such as temozolomide, radio-sensitizers such as efaproxiral), and more recently combination of radiation therapy with therapy targeting different signalling pathway were developed, for example with lapatinib for HER2 pathway. Targeted therapies acting on neoangiogenesis seem also may be considered as an interesting axis of research.